Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Switzerland / NCT06346132
Recruiting Not applicable

Effect of Virtual Reality on Patient's Comfort During Cardiac Electronic Device Implantation.

NCT06346132 · tracked via the Priya Life Science Switzerland tracker
Sponsor
Schlotterbeck Hervé
Phase
Not applicable
Started
2024-03-29
Last updated
2026-03-20

Condition(s) studied

Virtual RealityMedical DeviceLocal AnesthesiaPain

Investigational drug(s) / intervention(s)

Virtual reality application

Virtual reality application: In this group, virtual reality will be added to usual care

Study summary

The purpose of this study is to assess the effect on patient's comfort of a virtual reality experience during a procedure of cardiac electronic device implantation under local anesthesia.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients over 18 year old, * Patients who signed the consent form and accepted to participate to the trial, * New cardiac electronic device implantation or cardiac electronic device battery change, * Surgical procedure planned in ambulatory care. Exclusion Criteria: * Communication limitations, * Surgical procedure planned in sedation or narcosis, * Severe sensorial deficits (visual, auditory), * Claustrophobia, * Known motion sickness, * Patient isolated or with contact precautions, * Known or anticipated psychiatric diseases, * Patient known for epilepsia, * Opened scar and or ongoing infection at the level of the face and/or eyes, * Patient evaluated non suitable for the study by the surgeon, cardiologist or anesthetist.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istituto CardioCentro Lugano Canton Ticino Recruiting

Other trials for the same condition

Virtual Reality Training for Laparoscopic Cholecystectomy Recruiting
The Effect of an App-based Intervention on Quality of Life in Patients With Endometriosis. Recruiting
Does Virtual Reality Improve Symptom Burden in Dialysis Patients? Recruiting
Clinical Validation of BoneMRI in the Spine Recruiting
Individualized Analgesia in the Intensive Care Unit With a New Pain Assessment Bundle and Protocolized Analgesia Adjustments Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06346132 on ClinicalTrials.gov ↗ ← All trials in Switzerland